ARIA Financial Facts
Other income (expense), net: -62KIncome (loss) from operations: -64.55M
See Full Income Statement
Deferred revenue: 480K
Total stockholders' equity: 363.98M
See Full Balance Sheet
Earnings History for Ariad Pharmaceuticals Inc. (ARIA)
|
Expand Research on ARIA
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | -24.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -9.9% | Revenue Growth Rate | +7,801.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/25/13  |
 |
Q412 | -$0.36 | N/A | N/A | $74M | $78M | N/A / N/A | N/A | -16.1% | Details |
| 11/3/11 |
|
Q311 | $0.10 | $0.05 | +$0.05 | $25.1M | $26.13M | N/A / N/A | N/A | +55.9% | Details |
| 5/7/13 |
|
Q113 | -$0.36 | -$0.38 | +$0.02 | $6.4M | $5.01M | N/A / N/A | N/A | +2.5% | Details |
| 2/17/11 |
|
Q410 | -$0.25 | -$0.14 | -$0.11 | $525K | $1.42M | N/A / N/A | N/A | +183.7% | Details |
| 5/9/12 | Q112 | -$0.29 | -$0.26 | -$0.03 | $81K | $300K | N/A / N/A | N/A | +9.5% | Details | |
| 2/28/12 |
|
Q411 | -$0.38 | -$0.19 | -$0.19 | $78K | $940K | N/A / N/A | N/A | +17.3% | Details |
| 8/2/11 |
|
Q211 | -$0.36 | -$0.18 | -$0.18 | $66K | $930K | N/A / N/A | N/A | +47.3% | Details |
| 5/4/11 |
|
Q111 | -$0.29 | -$0.13 | -$0.16 | $56K | $4.07M | N/A / N/A | N/A | +119.6% | Details |
